STEVEN B. KETCHUM, PH.D. - Corporate Board Profile

Viracta Therapeutics, Inc.

Filing Date	Source Excerpt
2012-04-23	Steven B. Ketchum, Ph.D. served as our Senior Vice President, Research and Development from June 2008 to February 2012. In February 2012, Dr. Ketchum accepted the position of President of Research and Development, Senior Vice President at Amarin Corporation plc and concurrently transitioned from his executive role to a member of our Board. Director Compensation Table does not show compensation for Dr. Ketchum as a director.
2013-04-25	Steven B. Ketchum, Ph.D. served as our Senior Vice President, Research and Development from June 2008 to February 2012. ... Dr. Ketchum accepted the position of President of Research and Development, Senior Vice President at Amarin Corporation plc, a biopharmaceutical company, and concurrently transitioned from his executive role to a member of our Board. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2012. ... Steven B. Ketchum total compensation $76,730.
2014-04-24	Steven B. Ketchum, Ph.D. serves on the Audit and Compensation Committees. The compensation table shows total compensation of $103,546 for 2013.
2015-04-28	Steven B. Ketchum, Ph.D. served as our Senior Vice President, Research and Development from June 2008 to February 2012. In February 2012, Dr. Ketchum accepted the position of President of Research and Development, Senior Vice President at Amarin Corporation plc, a biopharmaceutical company, and concurrently transitioned from his executive role to a member of our Board. From May 2005 to May 2008, Dr. Ketchum served as Senior Vice President, Research & Development and Medical Affairs of Reliant Pharmaceuticals, Inc., a pharmaceutical company, which was acquired by GlaxoSmithKline in 2007. From June 2002 to April 2005, Dr. Ketchum served as Senior Vice President, Operations and Regulatory Affairs for IntraBiotics Pharmaceuticals, Inc. Dr. Ketchum also held positions at ALZA Corporation from November 1994 to May 2002, most recently as Senior Director, Regulatory Affairs. Dr. Ketchum earned a Ph.D. in Pharmacology from University College London (funded by the Sandoz Institute for Medical Research) and a B.S. in Biological Sciences from Stanford University. The Board has concluded Dr. Ketchum should serve on our Board due to his tenure at Sunesis and his scientific and regulatory expertise and industry background, which position him to make an effective contribution to the Board, and which the Board believes to be particularly important as we continue our drug development efforts and progress towards potential future regulatory filings. Director Compensation Table: Steven B. Ketchum Fees Earned or Paid in Cash ($): $40,000, Option Awards ($): $87,038, Total ($): $127,038.
2016-04-25	Steven B. Ketchum, Ph.D. served as our Senior Vice President, Research and Development from June 2008 to February 2012 and is currently a director. The Director Compensation Table shows total compensation of $124,652.
2017-04-20	Steven B. Ketchum, Ph.D. served as our Senior Vice President, Research and Development from June 2008 to February 2012. ... The Board has concluded Dr. Ketchum should serve on our Board due to his tenure at Sunesis and his scientific and regulatory expertise and industry background. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2016. Steven B. Ketchum received total compensation of $61,740.
2018-04-25	Steven B. Ketchum, Ph.D. served as our Senior Vice President, Research and Development from June 2008 to February 2012. ... The Board has concluded Dr. Ketchum should serve on our Board due to his tenure at Sunesis and his scientific and regulatory expertise. ... On December 12, 2017, Dr. Ketchum was appointed to the Nominating and Corporate Governance Committee. ... Steven B. Ketchum 40,000 fees earned, 58,915 option awards, total 98,915.
2019-04-12	Steven B. Ketchum, Ph.D. served as our Senior Vice President, Research and Development from June 2008 to February 2012. ... The Board has concluded Dr. Ketchum should serve on our Board due to his tenure at Sunesis and his scientific and regulatory expertise and industry background. ... Committees: Audit Committee, Nominating and Corporate Governance Committee. ... Director Compensation Table: Steven B. Ketchum Fees Earned or Paid in Cash $45,000, Option Awards $42,740, Total $87,740.
2020-04-28	Steven B. Ketchum, Ph.D. served as our Senior Vice President, Research and Development until 2012 and then transitioned to a member of our Board. The Director Compensation Table shows total compensation of $88,608 for 2019. He serves on the Audit Committee and the Nominating and Corporate Governance Committee.